MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Cash Flow Overview
Free Cash flow
$6,686K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Cash proceeds from long-term deb...
Net income
Depreciation
Others
Negative Cash Flow Breakdown
Principal payments on long-term ...
Common stock repurchased as part...
Accounts receivable
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income
3,231
1,017
2,036
2,259
Provision for doubtful accounts
143
69
98
63
Depreciation
3,001
3,044
3,138
3,070
Loss on disposal of and reserve adjustments for medical equipment
300
202
182
-43
Gain on sale of medical equipment
219
-123
1,026
559
Amortization of intangible assets
175
209
211
214
Amortization of deferred debt issuance costs
21
21
20
22
Stock-based compensation
1,242
1,233
1,272
1,322
Deferred income taxes
640
400
196
1,167
Accounts receivable
3,439
2,250
-2,430
78
Inventories
-796
203
-199
-78
Other current assets
-87
130
141
786
Other assets
-74
-563
914
78
Accounts payable and other liabilities
725
-3,328
-575
1,842
Net cash provided by operating activities
6,777
970
7,126
8,493
Acquisition of business
0
-
0
0
Purchase of medical equipment
4,863
1,680
2,785
1,027
Purchase of property and equipment
91
157
133
79
Proceeds from sale of medical equipment, property and equipment
431
577
726
854
Net cash used in investing activities
-4,523
-1,260
-2,192
-252
Principal payments on long-term debt
6,745
6,145
8,084
14,004
Cash proceeds from long-term debt
7,503
6,145
6,724
8,785
Debt issuance costs
0
-
-33
218
Common stock repurchased as part of share repurchase program
3,549
809
1,306
2,168
Common stock repurchased to satisfy statutory withholding on employee stock-based compensation plans
610
165
69
578
Cash proceeds from exercise of options and espp
5
184
-1
177
Net cash used in financing activities
-3,396
-790
-2,703
-8,006
Net change in cash and cash equivalents
-1,142
-1,080
2,231
235
Cash and cash equivalents, beginning of period
2,106
3,186
955
527
Cash and cash equivalents, end of period
964
2,106
3,186
955
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
INFU Cash Flow Sankey Diagram
Sankey diagram visualizing INFU cash flow for the period
Net income
$3,231K
(38.55%↑ Y/Y)
Depreciation
$3,001K
(-51.33%↓ Y/Y)
Stock-based compensation
$1,242K
(-29.79%↓ Y/Y)
Inventories
-$796K
(7.76%↑ Y/Y)
Accounts payable and
other liabilities
$725K
(136.71%↑ Y/Y)
Deferred income taxes
$640K
(-53.04%↓ Y/Y)
Loss on disposal of
and reserve...
$300K
(-21.05%↓ Y/Y)
Amortization of intangible
assets
$175K
(-64.65%↓ Y/Y)
Provision for doubtful
accounts
$143K
(266.67%↑ Y/Y)
Other current assets
-$87K
(-262.50%↓ Y/Y)
Other assets
-$74K
(93.31%↑ Y/Y)
Amortization of deferred debt
issuance costs
$21K
(-46.15%↓ Y/Y)
Net cash provided by
operating activities
$6,777K
(-22.89%↓ Y/Y)
Canceled cashflow
$3,658K
Net change in cash
and cash...
-$1,142K
(-691.71%↓ Y/Y)
Canceled cashflow
$6,777K
Proceeds from sale of
medical equipment,...
$431K
(-75.06%↓ Y/Y)
Cash proceeds from
long-term debt
$7,503K
(-77.07%↓ Y/Y)
Cash proceeds from
exercise of options and...
$5K
(-96.86%↓ Y/Y)
Accounts receivable
$3,439K
(64.62%↑ Y/Y)
Gain on sale of
medical equipment
$219K
(-87.29%↓ Y/Y)
Net cash used in
investing activities
-$4,523K
(-4.07%↓ Y/Y)
Canceled cashflow
$431K
Net cash used in
financing activities
-$3,396K
(20.09%↑ Y/Y)
Canceled cashflow
$7,508K
Purchase of medical
equipment
$4,863K
(12.73%↑ Y/Y)
Purchase of property and
equipment
$91K
(-73.85%↓ Y/Y)
Principal payments on
long-term debt
$6,745K
(-77.71%↓ Y/Y)
Common stock
repurchased as part of share...
$3,549K
(-44.50%↓ Y/Y)
Common stock
repurchased to satisfy...
$610K
(33.19%↑ Y/Y)
Buy us a coffee
InfuSystem Holdings, Inc (INFU)
InfuSystem Holdings, Inc (INFU)